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Abstract
Background: The additional purpose for pacemaker implantation, beyond treating arrhy-
thmias and conduction disturbances, is to improve the quality of life (QoL) of the patient. Most
previous research has shown this purpose to have been achieved. However, the question as to
whether all mental and physical components improve QoL to the same degree is still valid. The
purpose of this study is to evaluate changes in the primary mental and physical areas of QoL in
patients six months after they have had a pacemaker implanted.
Methods: Ninety eight patients with atrioventricular blocks (AVB) and 100 patients with
sinus node dysfunction (SND) who were qualified for pacemaker implantation were included
in this study. Every patient had a DDD(R)-type pacemaker with bipolar screw-in leads
implanted. The ventricular lead was positioned in the right ventricular outflow tract. QoL was
evaluated twice: three to five days before implantation and six months afterwards — the
MLWHF questionnaire was used.
Results: A very high statistical improvement in QoL (p ~ 0,0000) — reduced number of
points was found in all five areas of QoL in patients with SND and in four areas in patients
with AVB. In the ‘anxiety/depression area’ in patients with AVB, the average number of points
was higher (p = 0.3871), so QoL was worse.
Conclusions: Implanting a pacemaker improves QoL in patients with AVB and SND. In
patients with AVB, anxiety/depression is made more intense. (Cardiol J 2009; 16, 3: 250–253)
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Introduction
Since the implantation of the first cardiac pa-
cemaker in 1958 by Ake Sening and Rune Elmqvist,
there has been significant progress in this field of
medicine, including both the range of equipment and
the techniques of implantation [1, 2]. Most research
has shown these technologies can improve a pa-
tient’s health [3, 4]. Unfortunately, a huge number
of factors can interfere with the final results of
implantation (for instance, support of family and
friends, level of education, knowledge about proce-
dure). Doctors can too often see patients only as
clinical problems. But the psychological component
of recovery is also very important. Emotional disor-
ders, as a reaction of a patient to a somatic illness,
can be an independent factor of the disease [5].
There has been some research that has evaluated
the emotions of patients with implants, most looking
at what is known as quality of life (QoL) [6, 7]. Most
251
Rafał Młynarski et al., Quality of life after pacemaker implantation
www.cardiologyjournal.org
previous research has shown that this goal was at-
tained, but the question ‘Do all mental and physical
components improve QoL to a similar degree?’ is still
valid. The purpose of this study was to evaluate
changes in five main mental and physical areas of
QoL in patients six  months after they had a pace-
maker implanted.
Methods
Ninety eight patients with atrioventricular
blocks (AVB) and 100 patients with sinus node dys-
function (SND) who were qualified for pacemaker
implantation (aged 71.3 ± 8.7) were included in this
study (bioethical agreement no. NN-6501-23/05 was
obtained). The basic characteristics of the patients
are presented in Table 1. Optimal pharmacological
treatment of existing heart disease was confirmed
in all patients. We excluded patients with:
— a previously implanted pacemaker;
— chronotropic incompetence;
— both AVB and SND;
— persistent atrial fibrillation;
— severe heart failure (NYHA III or IV);
— other serious illnesses (such as cancer) that
could interfere with the results of QoL.
A DDD(R)-type pacemaker with bipolar screw-
in leads was implanted in each patient. The ventri-
cular lead was positioned in the right ventricular
outflow tract (87.4%). Due to technical problems or
unacceptable electric parameters, the right ventri-
cular lead was implanted into the interventricular
septum (10.1%) or apex (5.2%) in the rest of the
patients. The atrial lead was implanted in all patients
into the auricle of the right atrium. None of the spe-
cial functions for the pacemaker model was activa-
ted. AV delay was optimized four days after implan-
tation. QoL was evaluated twice: three to five days
before implantation and six months later. The Min-
nesota Living With Heart Failure (MLWHF)
questionnaire was used to evaluate QoL. This
questionnaire in essence measures the patient’s
perceptions of the effects of congestive heart failu-
re on their lives. But due to the similarity of the
symptoms of heart failure to those associated with
heart rhythm disorders, we decided to use it in the
research presented here. So, this 21-question
questionnaire featured a further five questions about
five basic areas of life. Some of the 21 questions pro-
ved too difficult for our patients (average ages 71.3).
Complete answers were obtained only to the five
questions evaluating how they felt in the following
areas: mobility, self-service, every day activity, pain
and anxiety/depression.
Statistical analysis
The Shapiro-Wilk test was used to check for
normality. For the statistical comparison of the re-
sults before and after pacemaker implantation, the
Wilcoxon test was used. Differences between the
group with AVB and the group with SND was
tested using the Mann-Whitney test. P < 0.05 was
recognized as statistically significant
Results
Summarized results  in the five main areas of
QoL in patients with AVB and SND (independen-
tly) are presented in Table 2. Values are presented
as median ± standard deviation (SD). The higher
the number of points, the lower the quality of life.
It can be seen that patients with AVB analyzed in
this study presented a more pronounced distortion
in all five areas of QoL when compared to the SND
group. Statistical improvement in QoL was found
in all areas of life, except one — the ‘anxiety and
depression’ area in patients with AVB. In those
patients, we found average worsening of the level
Table 1. Characteristics of patients included in
the study.
SND AVB
Number of patients 98 100
Men 43 (44%) 59 (59%)
Women 55 (56%) 41 (41%)
Etiology
Ischemic 28 (28.6%) 42 (42%)
Post infarction 26 (26.5%) 10 (10%)
Hypertension 15 (15.3%) 23 (23%)
Congenital 8 (8.2%) 2 (2%)
Idiopathic 15 (15.3%) 1 (1%)
Unspecified 6 (6.1%) 22 (22%)
Treatment
Beta-blockers 58 (59.2%) 55 (55%)
ACE inhibitors 79 (80.6%) 67 (67%)
Diuretic drugs 40 (40.8%) 33 (33%)
Glycosides 16 (16.3%) 17 (17%)
Follow-up
After-implantation – 1 (1%)
complications
Cardiological hospitalization 3 (3.1%) 9 (9%)
General hospitalization 13 (13.3%) 11 (11%)
Stroke – –
Death – –
SND — sinus node dysfunction; AVB — atrioventricular blocks
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of anxiety and/or depression. Additional compari-
son between groups with AVB and SND was also
performed. The results are presented in Table 3. The
values relating to anxiety and depression before im-
plantation were similar in both analyzed groups.
A significant difference was observed in the values
after implantation.
Discussion
Over the last 20 years, the results of several,
international, multi-center clinical trials in which
one of the purposes was quality of life evaluation
after implantation of a pacemaker, have been pu-
blished. In most, QoL as experienced by patients
with different types of pacing was evaluated. The
Canadian Trial of Physiologic Pacing (CTOPP) trial
was one of the larger investigations of this type.
This was a randomized investigation that compa-
red atrial-based pacing (AAIR or DDDR) to ventri-
cular pacing (VVIR). During three years of follow-
up, a significant reduction for DDDR was obtained
in the quantity of atrial fibrillation exclusively, but
this was connected with a higher number of com-
plications [8]. The quality of life was estimated
using SF-36 and SF-6 questionnaires; in all areas
no significant improvement was noted [6]. Mode Se-
lection Trial in Sinus Node Dysfunction (MOST)
was the second largest trial in which improvements
in the quality of life in patients with DDD pacema-
kers were proven. The results of the MOST trial,
as well as international guidelines, were the
theoretical basis for the research presented here.
For this reason, DDD pacemakers were implanted
in all patients included in this study [9].
The main aim of this research was to answer
the question: ‘Has QoL changed after six months
of follow-up, and if so, in which areas?’ in two sepa-
rate groups of patients, when the process of implan-
tation, the programming of the devices and the car-
diological treatment have been similar. In line with
our hypothesis, QoL statistically improved in both
groups, with one exception: anxiety and depression
in the group with atrioventricular blocks. In our
opinion, the results obtained can be explained by
the fact that symptoms before implantation are usu-
ally more intense in this group and patients usually
know about total ‘dependence’ on the pacemaker
after implantation. Therefore, we think that implan-
tation of a pacemaker does not remove anxiety but
Table 2. Average results in quality of life before/after implantation in five main areas of quality of life in
patients with atrioventricular blocks and sinus node dysfunction.
Sinus node dysfunction Atrioventricular blocks
Before After Before After
(X1 ± SD)   (X1 ± SD)  (X1 ± SD)  (X1 ± SD)
Mobility 0.70 ± 0.62 0.25 ± 0.25 Ø0.0000 0.91 ± 0.59 0.57 ± 0.63 Ø0.0002
Self-service 0.54 ± 0.62 0.23 ± 0.30 Ø0.0000 0.98 ± 0.67 0.56 ± 0.67 Ø0.0000
Every day activity 0.96 ± 0.74 0.46 ± 0.50 Ø0.0000 1.06 ± 0.78 0.59 ± 0.62 Ø0.0000
Pain 1.30 ± 0.71 0.61 ± 0.81 Ø0.0000 1.30 ± 0.77 0.80 ± 0.59 Ø0.0000
Anxiety/depression 1.03 ± 0,83 0,51 ± 0.50 Ø0.0000 1.02 ± 0.76 1.04 ± 0.74 ≠0.3871
1arithmetical mean in points (range 0–2), a lower value in points means higher physical/emotional state of the patient
Table 3. Comparison of the quality of life between the groups with atrioventricular blocks (AVB) and
sinus node dysfunction (SND).
Before (X1 ± SD) After (X1 ± SD)
SND AVB SND AVB
Mobility 0.70 ± 0.62 0.91 ± 0.59 ≠0.0161 0.25 ± 0.25 0.57 ± 0.63 ≠0.0001
Self-service 0.54 ± 0.62 0.98 ± 0.67 ≠0.0000 0.23 ± 0.30 0.56 ± 0.67 ≠0.0000
Every day activity 0.96 ± 0.74 1.06 ± 0.78 ≠0.1620 0.46 ± 0.50 0.59 ± 0.62 ≠0.0448
Pain 1.30 ± 0.71 1.30 ± 0.77 ~0.4989 0.61 ± 0.81 0.80 ± 0.59 ≠0.0129
Anxiety/depression 1.03 ± 0.83 1.02 ± 0.76 Ø0.4567 0.51 ± 0.50 1.04 ± 0.74 ≠0.0000
1arithmetical mean in points (range 0–2), a lower value in points means higher physical/emotional state of the patient
p
Wilcoxon
p
Wilcoxon
p
Mann-
-Whitney
p
Mann-
-Whitney
253
Rafał Młynarski et al., Quality of life after pacemaker implantation
www.cardiologyjournal.org
may sometimes intensify it. This is proven by the
results presented, which permit a practical conclu-
sion to be drawn, in addition to one hypothesis:
— patients with AVB should be educated more
carefully about life with a pacemaker;
— psychotherapy may be a useful method of sup-
port of these patients [10].
The results we present are generally consi-
stent with the results of major trials such as MOST
and CTOPP [9, 10]. A few studies, such as Stofmeel
et al., have used a modified SF-36 questionnaire for
patients with implanted pacemakers. This question-
naire is known as ‘Aquarel’. All these studies have
confirmed an improved quality of life in the groups
studied [6, 7, 11–13]. Unfortunately, not all studies
show such uniform conclusions: an example
is the results of the trial WHERE [14]. However, it
is difficult to compare these studies, mostly due to
the fact that different QoL questionnaires were
used.
Anxiety and depression are very common in
patients who have been in hospital and this is con-
nected with their somatic diseases. They can be
seen especially strongly in patients whose disease
might have very serious, unforeseeable problems.
Our research proves that this phenomenon is also
associated with patients with implanted pacema-
kers.
Limitations of the study
In the research presented here, we used the
MLWHF questionnaire, which is not officially de-
signed for patients after pacemaker implantation.
Only one questionnaire (Aquarel) is designed for
this group, but there are no validated national ver-
sions of it available. The large number of QoL tools
makes it difficult to compare results with other
studies. Another limitation to our study was the
brief period of follow-up (six months). We aim to
continue the presented research.
Conclusions
Implanting a DDD pacemaker improves the
quality of life in patients with AV blocks and in
patients with Sinus Node Dysfunction. Patients
qualified for implantation due to AVB showed more
pronounced (not statistically significant) emotional
problems, presenting as higher levels of anxiety and
depression.
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